SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
SIOX
Delisted
SIOX was delisted on the 22nd of March, 2023.
97 hedge funds and large institutions have $1.63B invested in Sio Gene Therapies Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 32 increasing their positions, 26 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
97
Holders Change
-4
Holders Change %
-3.96%
% of All Funds
2.42%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
16
Increased
32
Reduced
26
Closed
13
Calls
$26.7M
Puts
$12.1M
Net Calls
+$14.7M
Net Calls Change
+$7.68M
Top Buyers
| 1 |
Credit Agricole
Montrouge Cedex,
France
|
+$110M |
| 2 |
Primecap Management
Pasadena,
California
|
+$32.3M |
| 3 |
BlackRock
New York
|
+$15.9M |
| 4 |
ACA
Avoro Capital Advisors
New York
|
+$5.75M |
| 5 |
PVI
Pura Vida Investments
New York
|
+$5.68M |
Top Sellers
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$22.8M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$18.6M |
| 3 |
O
OppenheimerFunds
New York
|
-$3.66M |
| 4 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$2.69M |
| 5 |
EU
Emory University
Atlanta,
Georgia
|
-$1.97M |
